





















Cellular senescence, an irreversible cell-cycle arrest, acts 
as a safeguard program that limits the proliferative 
capacity of cells when exposed to endogenous or 
exogenous stress signals [1, 2]. However, the senescence 
phenotype is also considered as a sign that the life span of 
a cell has reached its end. Indeed, in the early 1960s, 
Hayflick and Moorhead showed that despite the 
maintenance of optimal culturing conditions for a long 
period of time, normal cells do not proliferate forever [3-
5]. For example, they observed that normal human 
diploid fibroblasts have a limited proliferation capacity 
and after a finite number of population doubling, they 
stop dividing and enter senescence. The occurrence of 
replicative senescence has been demonstrated for most 
cell types, with a few relevant exceptions including 
embryonic germ cells [6]. In human cells, the primary 
cause of cellular senescence appears to be the progressive 
shortening of telomeres, which are DNA structures at the 
end of eukaryotic chromosomes [7-9]. Senescence can 
also be induced by non-telomeric signals, termed 
“premature” or “accelerated” senescence [10]. 
Senescence-inducing signals, such as DNA-damage 
response (DDR) and oxidative stress (OS), usually 
engage either the p53 or the cyclin-dependent kinase 
inhibitor p16 pathway [11-14]. Active p53 establishes 
senescence, in part, by inducing the expression of the 
cyclin-dependent kinase inhibitor p21
cip, which 
suppresses the phosphorylation of the retinoblastoma 
protein pRB, leading to its inactivation [15].  
 
The importance of the senescence phenotype is under-
























opposite outcomes. Due to its antiproliferative effect, 
senescence is activated to prevent further growth of 
transformed or sick cells that are subsequently 
eliminated by the immune system [10, 16]. This effect 
has mainly been observed in young organisms, and as 
such senescence is considered a natural tumor 
suppressor mechanism [16-19]. On the other hand, the 
situation seems to change in aged individuals. Indeed, 
several studies have suggested that as we age, many 
senescent cells escape the immune system and end up 
accumulating in different tissues for a long period of 
time, which correlates with age-related diseases such as 
cancer [1, 16, 20]. This functional dichotomy of the 
senescence phenotype raises questions such as how and 
why the same conditions could lead to opposite 
outcomes depending on age. While the answers to these 
questions are still elusive, it is possible that the switch 
of senescent cells from being a natural break of tumor 
growth to becoming promoters of malignancy occurs 
over a long period of time as a consequence of repeated 
exposure to stress during the life-span of an organism. 
Since senescent cells remain metabolically active [7, 
19], these stresses could cause dramatic changes in the 
expression pattern of key genes which could explain 
how and why as we age senescent cells switch their 
function to become promoters of tumor growth. 
Although the expression patterns and the activities of 
the genes involved in promoting and maintaining the 
senescence state are well studied, very little is known 
about the effect stress could have on their expression 
when the cell are fully senescent.  
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senescent cells, incapable of further division, react to 
extracellular assaults. Our recent work [21] clearly 
indicated that in response to stress, senescent cells 
activate mechanisms that are similar to those seen in 
exponentially growing cells. We observed that fully 
senescent cells exposed to stresses such as oxidative 
stress (OS) or heat shock are able to form bonafide 
stress granules (SGs) [21]. Originally, SGs were 
identified as cytoplasmic RNA granules that form in 
mammalian cells upon exposure to various stresses [22-
24]. SG assembly represents one of the main 
prosurvival mechanisms through which cells cope with 
environmental assaults by helping them reprogram 
mRNA metabolism and repair stress-induced damage. 
We observed that when fully senescent human 
fibrobalsts exposed to either heat shock, or to arsenate 
(AS), a well-known inducer of OS, a much higher 
number of SGs form than in exponentially growing cells 
[21]. Since it is known that senescent cells have a 
decreased capacity to adapt to environmental stresses 
[25, 26], we assessed the impact of this high number of 
SGs on their ability to recover from these assaults. We 
observed that upon switching cells to AS-free media, 
SG disassembly in fully senescent cells occurs at a 
slower rate than in cells at earlier stages of the 
senescence process. Recent experiments performed in 
my laboratory support this observation and showed that 
in fully senescent cells there is a small but reproducible 
decrease in the expression levels of the heat shock 
protein 70 (HSP70), which is one of the key players 
involved in cell recovery from a variety of stresses [27, 
28] (Figure 1). This already suggested that while 
senescent cells maintained the ability to form SGs in 
response to stress, their recovery process was affected. 
This result is consistent with previous in vitro and in 
vivo studies showing that the expression of HSP70 
decreases in senescent cells exposed to stresses such as 
heat shock [29, 30]. Hence, together these data argue 
that the slow recovery rate observed in fully senescent 
cells [21] could be explained by the delayed expression 
of HSP70 protein. While SGs are entities used as a 
protective mechanism under stressful conditions, the 
fact that they take more time to disassemble in 
senescent cells upon stress removal could indicate a 
delay in the synthesis of many vital proteins needed for 
the maintenance of the senescence status.  
 
It is well accepted that in exponentially growing cells 
SGs recruit a variety of mRNA not only for protection 
from decay and sorting purposes but also to block their 
translation during cell exposure to stress [32]. As soon 
as the stress is relieved, however, SG disassemble and 
translation resumes. Hence, we investigated whether 






































































The  intensity  of  the  signal  in  each  lane  was  measured  using 
ImageQuant  software.  Each  bar  graph  represents  the  ratio  of 
Hsp70 over G3BP for each time point.  The histogram presents the 
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expression of the p21
cip mRNAs is dependent on the 
senescence stage of the cell [21]. We showed that 
although the p21
cip mRNAs colocalizes with SGs in 
both early and fully senescent cells, the synthesis of 
p21
cip protein was rapidly shut off only in fully 
senescent cells. The fact that these cells were treated 
with a sub-lethal dose of AS for only a short period of 
time (30 min), indicates that the events leading to the 
translation inhibition of p21
cip mRNA are triggered 
quickly and correlate with the assembly of SGs. This, 
however, does not explain why p21
cip translation is not 
affected in cells at earlier stages of the senescence 
process despite the fact that in these cells the p21
cip 
message is also rapidly recruited to SGs. Surprisingly, 
our data raise the possibility that senescent and 
normally growing cells use different molecular 
mechanism to assemble SGs in response to OS. We 
observed that in both early and fully senescent cells the 
phosphorylation of eIF2α, a key factor in AS-induced 
SG formation [33], is significantly reduced [21]. This 
result suggests that during the senescence process OS-
induced SG formation switches from an eIF2α 
phosphorylation-dependent mechanism to a process that 
is independent of this posttranslational modification. 
Work from several groups including ours, have 
demonstrated the existence of an eIF2α 
phosphorylation-independent mechanism for SG 
assembly. Indeed, cells exposed to Pateamine A or 
hippuristanol, two well-known inhibitors of the 
eukaryotic translation initiation factor A (eIF4A) form 
SGs in an eIF2α phosphorylation-independent manner 
[34, 35]. Although this or similar mechanisms could 
explain SGs formation in senescent cells exposed to OS, 
this possibility needs to be tested experimentally. 
Defining the mechanisms by which SGs assemble in 
senescent cells could open the door to screen for 
chemical inhibitors/activators that modulate SG 
formation in these cells. This could in turn provide tools 
to design new strategies that prevent senescent cell from 
promoting malignancy.  
 
In summary, delineating the functional relevance of SGs 
in senescent cells exposed to a variety of extracellular 
drugs could be relevant to the treatment of age-related 
diseases such as cancer. Indeed, many chemotherapeutic 
agents are used due to their ability to trigger senescence 
in cancer cells. Though a growing number of small 
molecules that induce irreversible cell cycle arrest in 
malignant cells have been recently developed, improve-
ment of cancer treatment is limited, underscoring the 
need for identifying the mechanisms by which these 
treatments could modify the behavior of senescent cells 
[10, 20, 36-38]. In fact, in some cases, malignant cells 








































become promoter of tumorigenesis; possibly by 
activating the senescence-associated secretory 
phenotypes (SASPs) [39, 40]. Indeed, in the work 
describing the impact of SASPs on cancer development, 
the Campisi laboratory showed that while treatment of 
human prostatic tumor cells with the DNA-damaging 
agent mitoxantrone (MIT) promote their entry to a 
senescence state, it also activates SASPs leading to the 
secretion of promalignant factors such as IL-6 and IL-8 
[39]. These two proinflammatory cytokines, are 
secreted in the microenvironement of senescent cells 
triggering epithelial-mesenchyme transition and 
invasiveness, two clear signs of tumor growth and 
metastasis. Although it is not known whether induction 
of senescence in the tumor cell itself could enhance 






translation  inhibition.  During  its  lifespan,  a  living  organism  is 
exposed repeatedly to a variety of stresses. This could trigger 
multiple  cycles  of  SGs  assembly/disassembly  which  in  turn 
change  the  expression  pattern  of  mRNAs  encoding  factors 
responsible  of  activation  the  senescence‐associated  secretory 
phenotypes (SASPs). Consequently, this could enhance the levels 
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transformation of neighboring cells that are not 
tumorigenic to become such. Since chemotherapeutic 
agents normally cause severe stresses, it is possible that 
some of them trigger the assembly and disassembly of 
SGs. If the mRNAs encoding SASPs factors are also 
recruited to these entities, the repeated cycles of 
translation inhibition/recovery could over time alter 
their expression pattern causing their massive synthesis 
and secretion in the surrounding environment. 
Exploring this possibility and defining whether or not 
SG assembly/disassembly plays a role in this outcome 
could help better understand why after being effective at 
early stages of the treatment some drugs revert and 
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